Since STING is a major regulator for intracellular DNA‐induced IFN‐I signaling, we knocked out Sting expression by CRISPR/Cas9 technology to reduce type I IFN expression in tumor cells (Figure S6A,B, Supporting Information). The gene discussed is STING1; the disease is neoplasm.